Oral delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: a case report.

Subject: ADD/ADHD - PUBLISHED VIA Journal of Clinical Psychopharmacology

Author(s):
Hasan A, Rothenberger A, Münchau A, Wobrock T, Falkai P, Roessner V

Department of Psychiatry and Psychotherapy, Georg-August-University Göttingen, Göttingen, Germany

View Source >> (Price: $49)

Related Studies:

View all medical studies

Learn More About Cannabis